XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF REDEEMABLE SERIES A-1 PREFERRED STOCK, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Redeemable Series A-1 Preferred Stock
Convertible And Redeemable Series A-2 Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019   $ 128,822          
Beginning balance, shares at Dec. 31, 2019   12,000          
Beginning balance at Dec. 31, 2019 $ (26,291)       $ 38,153 $ (64,404) $ (40)
Beginning balance, shares at Dec. 31, 2019       8,370,107      
Net loss (57,949)         (57,949)  
Accretion of the redeemable series A-1 preferred stock to redeemable value (17,601)       (17,601)    
Accretion of the redeemable series A-1 preferred stock to redeemable value   $ 17,601          
Series A-1 preferred stock deemed dividend   $ 24,341          
Series A-1 preferred stock deemed dividend $ (24,341)       (24,341)    
Redemption of the series A-1, shares (1,786,739)     1,786,739      
Temporary equity redemption of the series A-1, shares   (12,000)          
Redemption of the series A-1 preferred stock $ 26,801       26,801    
Temporary equity redemption of the series A-1   $ (170,764)          
Issuance of the convertible andredeemable series A-2 preferred stock     $ 152,928        
Issuance of the convertible and redeemable series A-2 preferred stock, Shares     17,500        
Dividend payment to the series A-2 preferred shareholders (6,970)   $ (7,000)   (6,970)    
Exercise of the series A-1 and A-2 preferred stock warrant 56,312       56,312    
Exercise of the series A-1 and A-2 preferred stock warrant, shares       2,534,239      
Stock-based compensation 4,849       4,849    
Common stock issued 25,383       25,383    
Common stock issued, shares       859,227      
Issuance of common stock in connection with initial public offering $ 156,841       156,841    
Issuance of common stock in connection with initial public offering, net of issuance costs of $15.6 million, shares       11,500,000      
Cancellation of shares (117,785)     (117,785)      
Accumulated other comprehensive income (loss) $ 111           111
Ending balance at Dec. 31, 2020     $ 152,928        
Ending balance, shares at Dec. 31, 2020     17,500        
Ending balance at Dec. 31, 2020 137,145       259,427 (122,353) 71
Ending balance, shares at Dec. 31, 2020       24,932,527      
Net loss (25,325)         (25,325)  
Dividend payment to the series A-2 preferred shareholders (16,400)   $ (16,400)   (16,400)    
Stock-based compensation 10,321       10,321    
Common stock issued 41,641       41,641    
Common stock issued, shares       1,812,394      
Issuance of common stock in connection with follow-on offering, net of issuance costs of $0.6 million 169,154       169,154    
Issuance of common stock in connection with follow-on offering, net of issuance costs of0.6 million, shares       2,875,000      
Accumulated other comprehensive income (loss) (35)           (35)
Ending balance at Dec. 31, 2021     $ 152,928        
Ending balance, shares at Dec. 31, 2021     17,500        
Ending balance at Dec. 31, 2021 316,501       464,143 (147,678) 36
Ending balance, shares at Dec. 31, 2021       29,619,921      
Net loss (31,819)         (31,819)  
Dividend payment to the series A-2 preferred shareholders (16,400)   $ (16,400)   (16,400)    
Stock-based compensation 43,290       43,290    
Common stock issued 1,643       1,643    
Common stock issued, shares       126,872      
Accumulated other comprehensive income (loss) (28)           (28)
Ending balance at Dec. 31, 2022     $ 152,928        
Ending balance, shares at Dec. 31, 2022     17,500        
Ending balance at Dec. 31, 2022 $ 313,187       $ 492,676 $ (179,497) $ 8
Ending balance, shares at Dec. 31, 2022       29,746,793